Coldstream Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,417
Closed -$23.5K 1118
2025
Q1
$23.5K Buy
+1,417
New +$23.5K ﹤0.01% 2037